Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-17.74	43.48	52.86
Graham Fair Price	-14.34	1.96	2.29
PEG	40.11	-0.73	0.52
Price/Book	-9.26	1.70	1.87
Price/Cash Flow	-68.14	31.43	-98.63
Prices/Earnings	16.31	17.83	15.33
Price/Sales	-19.65	3.88	4.83
Price/FCF	-68.14	31.43	-98.63
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	6.43	0.15	0.14
Operating Margin	7.90	0.07	0.06
ROA	-26.04	< 0.005	0.01
ROE	0.03	0.02	-21.98
ROIC	0.01	0.02	13.07
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.03	-0.04	-17.56
Dividends QOQ	0.16	9.22	5570.82
EBIT QOQ	-0.04	0.18	344.28
EPS QOQ	0.29	-0.24	-16.99
FCF QOQ	-1.34	3.76	181.26
Revenue QOQ	0.04	0.10	116.40
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	89.82	79.23	-11.79
Days Sales Outstanding (DSO)	94.17	93.26	-0.97
Inventory Turnover	1.00	1.14	13.37
Debt/Capitalization	0.41	0.43	3.75
Quick Ratio	0.89	0.95	6.88
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	2.76	2.82	2.18
Cash	1.47	1.54	4.66
Capex	< 0.005	0.06	947.54
Free Cash Flow	-0.05	0.14	176.22
Revenue	1.07	1.17	9.53
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.29	1.22	-5.37
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.47	4.11	-7.95
Naive Interpretation	Member

06 - Financial Health · Weak

Rating